Expect Equity LLC boosted its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) by 59.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 173,970 shares of the company’s stock after purchasing an additional 64,961 shares during the period. Expect Equity LLC’s holdings in Viemed Healthcare were worth $1,293,000 as of its most recent filing with the SEC.
Several other institutional investors also recently added to or reduced their stakes in the stock. Martingale Asset Management L P grew its position in Viemed Healthcare by 6.0% during the fourth quarter. Martingale Asset Management L P now owns 42,483 shares of the company’s stock valued at $316,000 after buying an additional 2,399 shares during the period. State of Alaska Department of Revenue bought a new position in Viemed Healthcare during the fourth quarter valued at about $25,000. Barclays PLC grew its position in Viemed Healthcare by 2.7% during the fourth quarter. Barclays PLC now owns 131,759 shares of the company’s stock valued at $979,000 after buying an additional 3,480 shares during the period. Invesco Ltd. grew its position in Viemed Healthcare by 25.5% during the second quarter. Invesco Ltd. now owns 18,652 shares of the company’s stock valued at $129,000 after buying an additional 3,795 shares during the period. Finally, Rhumbline Advisers grew its position in Viemed Healthcare by 9.0% during the second quarter. Rhumbline Advisers now owns 51,456 shares of the company’s stock valued at $356,000 after buying an additional 4,228 shares during the period. Institutional investors own 74.24% of the company’s stock.
Viemed Healthcare Price Performance
VMD opened at $10.53 on Thursday. The firm has a market cap of $403.72 million, a P/E ratio of 28.46 and a beta of 1.12. The firm has a 50-day moving average of $9.70 and a 200 day moving average of $8.64. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.22. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $10.68.
Insiders Place Their Bets
In other Viemed Healthcare news, President Michael Moore sold 65,000 shares of the stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $8.77, for a total transaction of $570,050.00. Following the completion of the transaction, the president owned 1,585,812 shares in the company, valued at $13,907,571.24. This trade represents a 3.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 20.00% of the stock is owned by corporate insiders.
Viemed Healthcare Profile
Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.
See Also
- Five stocks we like better than Viemed Healthcare
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report).
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
